EGFR and colorectal cancer: In colorectal cancer, high polysomy or amplification of EGFR was associated with response to cetuximab therapy, whereas loss of PTEN expression, (evaluated by IHC) rather is indicative for therapy resistance (Frattini et al, 2007; Laurent-Puig et al, 2009; Loupakis et al, 2009).